Teva Pharmaceutical Industries Ltd. is partnering with drug delivery specialist Microchips Biotech Inc. to develop a tiny implantable chip capable of storing and releasing hundreds of therapeutic doses of drug for periods ranging from months to years. If successful, the platform could potentially help the company win the favor of doctors, patients and payers, all of which stand to realize distinct advantages from the technology.